Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Marky1 on Feb 11, 2021 8:16pm

The Way I see it

Has anyone ever seen on Nasdaq a Pharm company spikes up from 5$ to over 100$...up 3,000% in a few days! I can see this happening with our beloved ANTIBE! There are so many positive things in the works. I'm sure that Dr.Haut is already talking to Bayer...They know him very well, thanks to the AskBio deal...and he knows them, who to talk to and how to put an offer on the table. It took him exactly 7 months to complete that deal, 

And don't forget Stern IR! They will play a key role Getting institutions on board , educating them on our great pipeline of drugs

Then we have Dr. Stauffer ( thank you Dan for getting these 2 talented people)...Joe, as I've already said, knows the FDA people in the NSAIDS division, knows what they want and expect from a P3 testing program
According to Christina " ANTIBE will not be completing the P3 testing "....meaning that we will be acquired long before completion 
Bonne Chance to us all...Going to be an amazing year..
Comment by Layth1990 on Feb 11, 2021 8:35pm
I totally agree with you, we have the best team when it comes to partnering or designing clinical trial. i believe we will get aquired half way through phase 3. It is just a matter of timr, the team is trying to utilize antibe true value so we can get aquired by a fair deal. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities